Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Multisystem inflammatory syndrome in children: Inputs of BNP, NT-proBNP and Galectin-3
Alexandre Raynor1, Clarisse Vallée1, Anne-Laure Belkarfa1
1Service de Biochimie Générale, AP-HP, Hôpital Universitaire Necker-Enfants malades, Paris, France.
Insights
NT-proBNP may be a more sensitive biomarker than BNP for early detection of heart failure in children with Multisystem Inflammatory Syndrome in Children (MIS-C). Galectin-3 levels were unaffected in MIS-C patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Biomarker Research
Background:
- Multisystem Inflammatory Syndrome in Children (MIS-C) is a post-COVID-19 condition affecting children.
- Cardiac involvement, including dysfunction and shock, occurs in 80-85% of MIS-C patients.
- Early identification of cardiac involvement is crucial for effective management.
Purpose of the Study:
- To compare the utility of three cardiac biomarkers: BNP, NT-proBNP, and Galectin-3.
- To assess these biomarkers in a cohort of French children hospitalized with MIS-C and cardiac involvement.
- To determine the most sensitive biomarker for detecting heart failure in MIS-C.
Main Methods:
- A cohort of 14 hospitalized children with MIS-C and cardiac involvement (confirmed by echocardiography) was studied.
- SARS-CoV-2 serology was positive in all participants.
- BNP, NT-proBNP, and Galectin-3 levels were measured at admission, discharge, and follow-up.
Main Results:
- Galectin-3 levels remained within the reference range and did not change significantly throughout the study period.
- Both BNP and NT-proBNP were elevated in children with cardiogenic shock compared to those without.
- NT-proBNP levels exceeded the positive predictive value for heart failure in both groups, while BNP levels were below the negative predictive value in children without cardiogenic shock but with cardiac dysfunction.
Conclusions:
- Galectin-3 does not appear to be a reliable biomarker for MIS-C-related cardiac issues.
- NT-proBNP shows potential as a more sensitive and earlier indicator of heart failure in MIS-C compared to BNP.
- NT-proBNP may be a valuable tool for screening heart failure in pediatric MIS-C patients.
Background:
Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock. Here, three cardiac biomarkers, BNP, NT-proBNP and Galectin-3 were compared for the first time in MIS-C in a unique cohort of hospitalized French children.
Methods:
Fourteen children with MIS-C hospitalized at Necker-Enfants Malades for cardiac management during the first three COVID-19 waves (March 2020-March 2021) were included. All had positive SARS-CoV-2 serology and proven cardiac involvement assessed by transthoracic echocardiography. NT-proBNP, BNP and Galectin-3 were measured at admission, discharge and first follow-up clinic.
Results:
All admission Galectin-3 measurements were comprised within the reference interval, both in patients with and without cardiogenic shock, and did not vary between admission, discharge and first follow-up clinic. Both median admission BNP and NT-proBNP were higher in children with cardiogenic shock than without. Median admission NT-proBNP was higher than its predictive positive value in heart failure in both groups of children, while median BNP was below its negative predictive value in children without cardiogenic shock but with cardiac dysfunction.
Conclusions:
Galectin-3 does not seem affected by MIS-C. NT-proBNP seems to increase more precociously than BNP possibly making it a more sensitive marker for screening of heart failure in MIS-C.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests
Nephrotic Syndrome I : Introduction

